269 related articles for article (PubMed ID: 3220118)
1. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
[TBL] [Abstract][Full Text] [Related]
2. Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain.
Kashihara K; Sato M; Fujiwara Y; Harada T; Ogawa T; Otsuki S
Biol Psychiatry; 1986 Jun; 21(7):650-6. PubMed ID: 3011131
[TBL] [Abstract][Full Text] [Related]
3. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
Chivers JK; Reavill C; Jenner P; Marsden CD
J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027
[TBL] [Abstract][Full Text] [Related]
4. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
Toide K; Unemi N; Segawa T
Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):111-24. PubMed ID: 3925907
[TBL] [Abstract][Full Text] [Related]
5. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
de Graaf CJ; Korf J
Psychopharmacology (Berl); 1986; 90(1):54-7. PubMed ID: 3094062
[TBL] [Abstract][Full Text] [Related]
6. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
[TBL] [Abstract][Full Text] [Related]
7. Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolite levels.
MacRae PG; Spirduso WW; Cartee GD; Farrar RP; Wilcox RE
Neurosci Lett; 1987 Aug; 79(1-2):138-44. PubMed ID: 2959886
[TBL] [Abstract][Full Text] [Related]
8. Reduced haloperidol: effects on striatal dopamine metabolism and conversion to haloperidol in the rat.
Korpi ER; Wyatt RJ
Psychopharmacology (Berl); 1984; 83(1):34-7. PubMed ID: 6204352
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
Bettini E; Ceci A; Spinelli R; Samanin R
Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
[TBL] [Abstract][Full Text] [Related]
10. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
See RE
Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
[TBL] [Abstract][Full Text] [Related]
11. Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.
Kaneno S; Watanabe A; Takahashi R
Eur J Pharmacol; 1986 Apr; 123(2):287-94. PubMed ID: 3086109
[TBL] [Abstract][Full Text] [Related]
12. Effect of buflomedil (4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxy phenyl)-1-butanone hydrochloride) on the function of striatal dopaminergic neurons.
Koda H; Hashimoto T; Kuriyama K
Jpn J Pharmacol; 1989 Feb; 49(2):215-23. PubMed ID: 2659861
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of acute and subacute HA-966 treatment on storage and release of striatal dopamine.
Broxterman HJ; Noach EL; Van Valkenburg CF
Eur J Pharmacol; 1979 Dec; 60(2-3):153-61. PubMed ID: 527656
[TBL] [Abstract][Full Text] [Related]
14. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
Meller E; Friedman E
Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921
[TBL] [Abstract][Full Text] [Related]
15. Time-related changes in serum perphenazine, striatal 3H-spiperone binding and regional brain acid metabolites of dopamine and 5-hydroxy-tryptamine after a single dose of perphenazine.
Mjörndal T; Persson SA
Fundam Clin Pharmacol; 1990; 4(2):213-22. PubMed ID: 1693589
[TBL] [Abstract][Full Text] [Related]
16. Effects of cyclo (Leu-Gly) on neurochemical indices of striatal dopaminergic supersensitivity induced by prolonged haloperidol treatment.
Le Douarin C; Fage D; Scatton B
Life Sci; 1984 Jan; 34(4):393-9. PubMed ID: 6694528
[TBL] [Abstract][Full Text] [Related]
17. Repeated haloperidol administration changes basal release of striatal dopamine and subsequent response to haloperidol challenge.
Zhang W; Tilson H; Stachowiak MK; Hong JS
Brain Res; 1989 Apr; 484(1-2):389-92. PubMed ID: 2713698
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
20. Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats.
DeLucia R; Scavone C; Camillo MA
Braz J Med Biol Res; 1989; 22(6):741-3. PubMed ID: 2620186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
